Development of a new head and neck cancer-specific comorbidity index.

BACKGROUND Most patients with head and neck squamous cell carcinoma are older and may have coexistent or comorbid diseases. OBJECTIVES To determine the prognostic impact of individual comorbid conditions in patients with head and neck cancer, to combine the individual comorbid conditions to form a new a head and neck-specific comorbidity instrument, and to compare it with the Modified Kaplan-Feinstein Index to determine if the new disease-specific instrument offers any improvement in survival prediction over a general comorbidity index. DESIGN Retrospective review of medical records. POPULATION The study population comprised 1153 patients with biopsy-proven, newly diagnosed squamous cell carcinoma of the oral cavity, oropharynx, or larynx. RESULTS Seven comorbid conditions (congestive heart disease, cardiac arrhythmia, peripheral vascular disease, pulmonary disease, renal disease, cancer controlled, and cancer uncontrolled) were significantly related to survival. These comorbid conditions were assigned integer weights to reflect their relative prognostic importance and combined to create the new Washington University Head and Neck Comorbidity Index (WUHNCI). Survival was significantly related to levels of comorbidity severity as defined by the WUHNCI. The WUHNCI predicted survival better than the Modified Kaplan-Feinstein Index despite containing far fewer ailments. CONCLUSIONS Comorbidity is an important feature of the patient with head and neck cancer. The WUHNCI can be used for retrospective review or prospective outcomes research.

[1]  C B Granger,et al.  Risk stratification and therapeutic decision making in acute coronary syndromes. , 2000, JAMA.

[2]  J. Piccirillo,et al.  Importance of Comorbidity in Head and Neck Cancer , 2000, The Laryngoscope.

[3]  A. Dmitrienko,et al.  A comprehensive prognostic index to predict survival based on multiple comorbidities: a focus on breast cancer. , 1999, Medical care.

[4]  K. Covinsky,et al.  Assessing the Generalizability of Prognostic Information , 1999, Annals of Internal Medicine.

[5]  J. Piccirillo,et al.  Symptoms as an Index of Biologic Behavior in Head and Neck Cancer , 1999, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[6]  L. E. Rohde,et al.  A new casemix adjustment index for hospital mortality among patients with congestive heart failure. , 1998, Medical care.

[7]  R. Rosenfeld,et al.  Impact of comorbidity on outcome of young patients with head and neck squamous cell carcinoma , 1998, Head & neck.

[8]  D. Thomas,et al.  Alcoholism: independent predictor of survival in patients with head and neck cancer. , 1996, Journal of the National Cancer Institute.

[9]  R E Hall,et al.  Searching for an improved clinical comorbidity index for use with ICD-9-CM administrative data. , 1996, Journal of clinical epidemiology.

[10]  C. Wells,et al.  New Clinical Severity Staging System for Cancer of the Larynx , 1994, The Annals of otology, rhinology, and laryngology.

[11]  Max H. Myers,et al.  Manual for Staging of Cancer , 1992 .

[12]  A R Feinstein,et al.  A Clinical‐Severity Staging System for Patients with Lung Cancer , 1990, Medicine.

[13]  R. Elashoff,et al.  Flaws in mortality data. The hazards of ignoring comorbid disease. , 1988, JAMA.

[14]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.

[15]  A R Feinstein,et al.  Cancer of the larynx: a new staging system and a re-appraisal of prognosis and treatment. , 1977, Journal of chronic diseases.

[16]  A. Feinstein,et al.  The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. , 1974, Journal of chronic diseases.

[17]  Daniel B. Mark,et al.  TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS , 1996 .

[18]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.